Jack Nathan Health Announces Its Q1 Fiscal 2026 Financial Results

Executive Summary

• Jack Nathan Medical Corp. released its unaudited interim consolidated financial results for the first quarter of fiscal 2026 (three months ended April 30, 2025), reporting a slight decrease in total revenues and a net loss from operations.
• The company is undergoing a significant transitional period following the divestiture of its Canadian medical clinic and licensee business in December 2024, shifting its strategic focus toward building a sustainable MedSpa platform in Canada.
• All operations in Mexico were fully ceased as of June 30, 2025, following the termination of the agreement with Walmart Mexico, marking the end of the Company's active business in that region.

Key Details

• Revenues: Total consolidated revenues from continuing operations were $1,990,101 for Q1 2026, a 4% decrease from $2,079,867 in the same period of the prior year.
• MedSpa Performance: MedSpa revenues were $185,259 (9% of total revenues), down 11% year-over-year from $207,002 (10% of total revenues). Management expects MedSpa revenues to increase in subsequent quarters as clinics mature.
• Operating Results:
  • Operating expenses: $(2,821,060) (vs. $(2,764,803) in prior year).
  • Loss from operations: $(830,959) (vs. $(684,936) in prior year).
• Balance Sheet (as of April 30, 2025):
  • Cash: $0.91 million (down from $2.2 million at Jan 31, 2025).
  • Total Assets: $2.65 million (down from $3.54 million at Jan 31, 2025).
  • Total Liabilities: $2.45 million (up from $2.22 million at Jan 31, 2025).
• Share Count:
  • Common Shares Outstanding: 87,099,159.
  • Stock Options Outstanding: 1,300,000.
  • DSUs Outstanding: 335,004.
• Operational Changes:
  • Canada: Divestiture of Canadian medical clinic and licensee business completed in December 2024; focus now on MedSpa platform.
  • Mexico: Operations ceased as of June 30, 2025, following the formal termination of the agreement with Walmart Mexico. Mexico division is no longer part of active business.
• Filing Status: The Company completed its Q1 fiscal 2026 interim financial statements, MD&A, and CEO/CFO certifications within the permitted 90-day period, resolving previous delays caused by audit processes and operational restructuring.

Notable Quotes

• Mike Marchelletta, Chief Executive Officer: “Q1 represented a transitional period for Jack Nathan Health following the divestiture of our Canadian medical clinic and licensee business in December 2024. Our focus is now on building a sustainable MedSpa platform in Canada. We expect revenue contributions from MedSpa to grow in the upcoming quarters as our clinics continue to mature and gain customer traction.”